D2V DOSE2VALUE CLINICAL Trademark

Trademark Overview


On Wednesday, May 17, 2023, a trademark application was filed for D2V DOSE2VALUE CLINICAL with the United States Patent and Trademark Office. The USPTO has given the D2V DOSE2VALUE CLINICAL trademark a serial number of 98000754. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2024. This trademark is owned by D2V Inc.. The D2V DOSE2VALUE CLINICAL trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others
d2v dose2value clinical

General Information


Serial Number98000754
Word MarkD2V DOSE2VALUE CLINICAL
Filing DateWednesday, May 17, 2023
Status700 - REGISTERED
Status DateTuesday, August 13, 2024
Registration Number7471619
Registration DateTuesday, August 13, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements


Description of MarkThe mark consists of the letter "D" formed by squares to the right of two squares aligned vertically with one larger square to the left of the two squares, and the letter "V" on the right with the number two overlapping the letters "D" and "V" in which each character is in an outlined stylized font, and the words "DOSE2VALUE CLINICAL" in smaller font below "D2V".
Pseudo MarkDOSE TO VALUE DOSE TO VALUE CLINICAL; DOSE TWO VALUE DOSE TWO VALUE CLINICAL
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
NOT AVAILABLECLINICAL
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, June 17, 2023
Primary Code035
First Use Anywhere DateWednesday, April 26, 2023
First Use In Commerce DateWednesday, April 26, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, June 17, 2023
Primary Code042
First Use Anywhere DateWednesday, April 26, 2023
First Use In Commerce DateWednesday, April 26, 2023

Trademark Owner History


Party NameD2V Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameD2V Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameD2V Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Trademark Events


Event DateEvent Description
Saturday, May 20, 2023NEW APPLICATION ENTERED
Saturday, June 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 20, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, February 9, 2024ASSIGNED TO EXAMINER
Friday, February 9, 2024NON-FINAL ACTION WRITTEN
Friday, February 9, 2024NON-FINAL ACTION E-MAILED
Friday, February 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED